Tolckmitt W, Lohmann A, Kutschera J
Klin Padiatr. 1981 Sep;193(5):365-9. doi: 10.1055/s-2008-1034498.
The article reports on a study to determine the influence of different dosage schedules of a pancreas enzyme preparation on the digestion of fat and protein and on the lipolytic, tryptic and chymotryptic activity of the faeces in children suffering from mucoviscidose. After administration of the pancreatin preparation at the low dose level, the quantity of faeces, the excretion of fatty acids and of nitrogen are reduced and the absorption coefficient is improved. The faecal tryptic and chymotryptic activity increases, whereas the lipase activity in the faeces merely shows a tendency to rise. Increasing the pancreatin dose up to a still tolerable value by doubling the dosage does not result in further reduction of the excretion of fat and nitrogen although it enhances the proteolytic activity of the faeces while the lipase activity remains unaffected. Determination of the lipolytic, tryptic or chymotryptic activity is, therefore, unsuitable for assessing the fat and protein digestion and for estimating the required dose of pancreatic enzyme. No increase in uric acid excretion was seen in the urine collected for 24 hours after administration of both enzyme doses.
该文章报道了一项研究,旨在确定胰腺酶制剂的不同给药方案对患有粘多糖病的儿童脂肪和蛋白质消化以及粪便中脂肪分解、胰蛋白酶和糜蛋白酶活性的影响。在低剂量水平给予胰酶制剂后,粪便量、脂肪酸和氮的排泄减少,吸收系数提高。粪便中胰蛋白酶和糜蛋白酶活性增加,而粪便中的脂肪酶活性仅呈现上升趋势。将胰酶剂量加倍至仍可耐受的值,虽然会增强粪便的蛋白水解活性且脂肪酶活性不受影响,但不会导致脂肪和氮排泄的进一步减少。因此,测定脂肪分解、胰蛋白酶或糜蛋白酶活性不适用于评估脂肪和蛋白质消化以及估计所需的胰腺酶剂量。给予两种酶剂量后,收集的24小时尿液中尿酸排泄未见增加。